Skip to Content, Navigation, or Footer.
The Tufts Daily
Where you read it first | Sunday, February 25, 2024

Mariel Priven


Bite-Size Science: Boston Children's Hospital develops COVID-19 neutralizing antibody in mice

Researchers at Boston Children’s Hospital have developed an antibody capable of neutralizing all known SARS-CoV-2 variants in pre-clinical assessments, according to an August pre-print. The study published within Science Immunology, presents a potential solution to future variants of concern, as this is the first effective antibody that neutralizes all major variants through the recent Omicron BA.5 variant.


This week in Science: FDA okays e-cig, first malaria vaccine approved, toilet bats discovered

The U.S. Food and Drug Administrationgranted market authorization to an electronic cigarette company for the first time on Tuesday, approving certain products for sale in the United States. The FDAapproved three products from R.J. Reynolds Vapor Company’s brand, Vuse, in an effort to diminish the impacts of traditional cigarettes, whose carcinogenic properties contribute to an estimated 400,000 U.S. deaths each year. The FDA concluded that the reduced morbidity and mortality among smokers outweigh the risks that approving Vuse products poses to youth. Notably, 10% of high school students who use e-cigarettes said Vuse is their usual brand.

More articles »